Svante Vikingsson

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Characterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method

Systematic web monitoring of drug test subversion strategies in the United States

Fentanyl as a marker of illicit drug use in morphine-positive urine specimens from workplace drug testing

Prevalence of ∆8-tetrahydrocannabinol carboxylic acid in workplace drug testing

Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid-An unlikely cause of positive drug tests

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

In Vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3-fluoro-methoxyacetylfentanyl and 3-phenylpropanoylfentanyl using LC-QTOF-HRMS together with synthesized references

Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances - A Swedish strategy to protect public health from harm

Systematic in vitro metabolic profiling of the OXIZID synthetic cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID

Chiral separation and quantitation of methylphenidate, ethylphenidate, and ritalinic acid in blood using supercritical fluid chromatography

Performance of hair testing for cocaine use - Comparison of five laboratories using blind reference specimens

Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis

Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens

Characterisation of the monoamine transport inhibition of 28 new psychoactive stimulants

CB1 activity of three classes of synthetic cannabinoids and their metabolites – The tail needs to know what the head is doing

Update on urine adulterants and synthetic urine samples to subvert urine drug testing

Conversion of 7-carboxy-cannabidiol (7-COOH-CBD) to 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH) during sample preparation for GC-MS analysis

The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays

Circumstances, postmortem findings, blood concentrations and metabolism in a series of methoxyacetylfentanyl-related deaths